gi pathology in immunosuppressed patients
TRANSCRIPT
![Page 1: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/1.jpg)
GI pathology in
immunosuppressed
patients
Newton ACS Wong
Department of Cellular Pathology
Southmead Hospital
Bristol
![Page 2: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/2.jpg)
Which “immunosuppressed
patients” ?•HIV/AIDS patients
•Therapeutic immunosuppression
– Oncology treatment
– Transplantation:
•Solid organ
•Bone marrow
•[Not primary
immunodeficiencies]
![Page 3: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/3.jpg)
![Page 4: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/4.jpg)
Talk plan
•Diseases common to several
immunosuppressed groups
– Infection
– Neoplasia
– Drugs
•Diseases specific to certain
immunosuppressed groups
![Page 5: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/5.jpg)
Infection
•Bacteria
– Infectious colitides
![Page 6: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/6.jpg)
![Page 7: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/7.jpg)
![Page 8: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/8.jpg)
![Page 9: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/9.jpg)
![Page 10: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/10.jpg)
ZN+, thus: Mycobacteria
![Page 11: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/11.jpg)
PAS +ve
![Page 12: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/12.jpg)
2. 23M. MSM. 10 cms long stricture in rectum and anus, clinically & radiologically
malignant. The surgeon was sharpening his scalpel in the MDTM helped by the
usual confidently expressed diagnosis by the radiologist. A total of 20 separate
biopsies, in two settings, showed fibrinopurulent exudate, granulation tissue and
inflamed fibromuscular connective tissue with no mucosa, no granulomas and no
tumour.
Coronal and sagittal MRI images of the pelvis
![Page 13: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/13.jpg)
2. This is before and after treatment, with eight weeks separating them. Note the
massively thickened rectum before treatment (left) and the normal calibre rectum
after treatment (right). What’s the diagnosis and what was the treatment?
![Page 14: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/14.jpg)
32 year old male presented bloody diarrhoea
? IBD
![Page 15: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/15.jpg)
Same patient 8 weeks later
![Page 16: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/16.jpg)
Soni S, Srirajaskanthan R, Lucas SB, Alexander S, Wong T, White JA.
Lymphogranuloma venereum proctitis masquerading as inflammatory bowel disease
in 12 homosexual men. Aliment Pharmacol Ther. 2010 Jul;32(1):59-65.
![Page 17: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/17.jpg)
Viruses
![Page 18: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/18.jpg)
Herpes simplex virus
![Page 19: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/19.jpg)
71 female with
heartburn.
Previous hx of
resected CRC.
OGD: Severe
oesophagitis
![Page 20: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/20.jpg)
![Page 21: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/21.jpg)
CMV oesophagitis
(Patient was receiving
5FU-based chemoRx)
![Page 22: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/22.jpg)
CMV •HIV/AIDS, transplant and chemoRx
patients:
– Inflammation and viral inclusions
– Crypt apoptosis alone
![Page 23: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/23.jpg)
Sigmoid colonic tumour
![Page 24: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/24.jpg)
Biopsies of sigmoid colonic tumour
![Page 25: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/25.jpg)
![Page 26: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/26.jpg)
CMV •HIV/AIDS, transplant and chemoRx
patients:
– Inflammation and viral inclusions
– Crypt apoptosis alone
– Present as a focal lesion
![Page 27: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/27.jpg)
![Page 28: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/28.jpg)
![Page 29: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/29.jpg)
Adenovirus
![Page 30: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/30.jpg)
Viruses
•EBV – PTLD and smooth muscle
tumours
•HHV8 – Kaposi sarcoma
•HPV – anal squamous
neoplasia
![Page 31: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/31.jpg)
Fungi and parasites
![Page 32: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/32.jpg)
![Page 33: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/33.jpg)
Cryptosporidia
![Page 34: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/34.jpg)
![Page 35: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/35.jpg)
Giardia
![Page 36: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/36.jpg)
![Page 37: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/37.jpg)
Leishmania
![Page 38: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/38.jpg)
Neoplasia
•Lymphoid
•Epithelial
•Mesenchymal
![Page 39: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/39.jpg)
Epstein Barr virus &
Post-transplant
lymphoproliferative disease
(PTLD)
•Solid organ >> bone marrow
![Page 40: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/40.jpg)
Monomorphic PTLD
![Page 41: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/41.jpg)
Monomorphic PTLD
CD20 EBER
![Page 42: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/42.jpg)
Polymorphic PTLD
![Page 43: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/43.jpg)
Polymorphic PTLD
CD20 EBER
![Page 44: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/44.jpg)
Polymorphic PTLD
EBER
![Page 45: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/45.jpg)
Polymorphic PTLD
![Page 46: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/46.jpg)
Polymorphic PTLD
EBER
![Page 47: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/47.jpg)
Neoplasia
•Lymphoid
– PTLD (polymorphic type can
mimic Crohn’s disease)
![Page 48: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/48.jpg)
![Page 49: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/49.jpg)
Neoplasia
•Lymphoid
– PTLD (polymorphic type can
mimic Crohn’s disease)
– EBV driven GIT lymphomas and
immunosuppression – e.g. IBD
– HIV and lymphomas (primary
effusion lymphoma – HHV8)
![Page 50: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/50.jpg)
Neoplasia
•Epithelial
– Anal squamous dysplasia and
squamous cell carcinoma
![Page 51: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/51.jpg)
Neoplasia •Mesenchymal
– Kaposi sarcoma (can be CD117 +ve
but is DOG1 -ve)
![Page 52: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/52.jpg)
• In HIV/AIDS patients, EBV driven
smooth muscle neoplasms:
– less pleomorphism
– low mitotic count
![Page 53: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/53.jpg)
Drugs •Diarrhoea and:
– Antiretrovirals
– Cyclosporine
– Tacrolimus
•Mycophenolate mofetil (MMF)
![Page 54: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/54.jpg)
MMF
•Oesophagus to Colorectum
•Histological patterns
– GvHD like
– IBD like
– Combinations
– (Dilated damaged crypts)
![Page 55: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/55.jpg)
MMF
![Page 56: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/56.jpg)
Talk plan
•Diseases common to several
immunosuppressed groups
– Infection
– Neoplasia
– Drugs
•Diseases specific to certain
immunosuppressed groups
![Page 57: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/57.jpg)
Gastrointestinal GvHD
•BMT rather than solid organ
transplant patients
•Hallmark histological feature is
apoptosis
– Proliferative compartments
![Page 58: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/58.jpg)
![Page 59: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/59.jpg)
![Page 60: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/60.jpg)
Gastrointestinal GvHD
•Can include:– Acute inflammation
– Granulomas?
![Page 61: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/61.jpg)
Granulomas in GI GvHD?
![Page 62: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/62.jpg)
![Page 63: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/63.jpg)
Gastrointestinal GvHD
•Other causes of apoptosis
– Conditioning drugs (< Day 21)
– Mycophenolate mofetil (MMF)
– Viruses
![Page 64: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/64.jpg)
![Page 65: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/65.jpg)
Control grp: Non-BMT patients
investigated for GI symptoms or
being followed up for colorectal
polyps
![Page 66: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/66.jpg)
![Page 67: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/67.jpg)
When assessing transplant
patient GI biopsies
•Time from transplant?
•Transplant type?
•Underlying disease?
•GvHD elsewhere?
•MMF therapy?
•CMV, Adenovirus and EBV
titres?
![Page 68: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/68.jpg)
![Page 69: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/69.jpg)
![Page 70: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/70.jpg)
![Page 71: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/71.jpg)
Granulomas in GI GvHD?
![Page 72: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/72.jpg)
![Page 73: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/73.jpg)
![Page 74: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/74.jpg)
Underlying condition
requiring transplant
•BMT transplant– Lymphoma/leukaemia
![Page 75: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/75.jpg)
Underlying condition
requiring transplant
•Renal transplant– Amyloid
![Page 76: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/76.jpg)
Underlying condition
requiring transplant
•Liver transplant– Portal colopathy
– Primary sclerosing cholangitis and IBD
![Page 77: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/77.jpg)
Transplantation and IBD
•Does transplantation improve
or worsen IBD?
![Page 78: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/78.jpg)
![Page 79: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/79.jpg)
Transplantation and IBD
•Does transplantation improve
or worsen IBD?
• Immunosuppression helps but
restoration of normal liver
function has opposite effect.
![Page 80: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/80.jpg)
Other specific associations
•Solid organ transplant patients
– Gastric and duodenal ulcers
![Page 81: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/81.jpg)
Other specific associations
•Solid organ transplant patients
– Gastric and duodenal ulcers
•HIV/AIDS patients– Oesophageal and anal ulcers
– Enterocolopathy (apoptosis and
villous atrophy)
![Page 82: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/82.jpg)
23M AML patient
![Page 83: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/83.jpg)
•Pneumatosis coli:
•Colitis but no …
![Page 84: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/84.jpg)
Leukaemia and
neutropaenic colitis
![Page 85: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/85.jpg)
Summary
•Rare and/or multiple pathology
•Clinical data are crucial –
especially when considering
GvHD
![Page 86: GI pathology in immunosuppressed patients](https://reader034.vdocuments.site/reader034/viewer/2022050302/626ee4a470462a765c263708/html5/thumbnails/86.jpg)
When assessing transplant
patient GI biopsies
•Time from transplant?
•Transplant type?
•Underlying disease?
•GvHD elsewhere?
•MMF therapy?
•CMV, Adenovirus and EBV
titres?